Tower Research Capital (TRC)’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.7K | Sell |
3,852
-6,364
| -62% | -$37.6K | ﹤0.01% | 3303 |
|
|
2026
Q1 | $42K | Buy |
10,216
+7,481
| +274% | +$36.2K | ﹤0.01% | 2901 |
|
|
2025
Q4 | $18.2K | Sell |
2,735
-369
| -12% | -$2.5K | ﹤0.01% | 3170 |
|
|
2025
Q3 | $19.1K | Sell |
3,104
-4,260
| -58% | -$33.2K | ﹤0.01% | 3357 |
|
|
2025
Q2 | $67.8K | Buy |
7,364
+5,691
| +340% | +$58.2K | ﹤0.01% | 2711 |
|
|
2025
Q1 | $20.1K | Sell |
1,673
-19,823
| -92% | -$259K | ﹤0.01% | 2959 |
|
|
2024
Q4 | $237K | Buy |
21,496
+17,993
| +514% | +$253K | ﹤0.01% | 1599 |
|
|
2024
Q3 | $56.7K | Sell |
3,503
-1,475
| -30% | -$20.6K | ﹤0.01% | 2650 |
|
|
2024
Q2 | $54K | Buy |
4,978
+4,210
| +548% | +$51.8K | ﹤0.01% | 3046 |
|
|
2024
Q1 | $10.8K | Sell |
768
-9,108
| -92% | -$118K | ﹤0.01% | 3657 |
|
|
2023
Q4 | $104K | Sell |
9,876
-1,732
| -15% | -$15.5K | ﹤0.01% | 2620 |
|
|
2023
Q3 | $106K | Buy |
11,608
+10,289
| +780% | +$92.3K | ﹤0.01% | 1938 |
|
|
2023
Q2 | $9.59K | Buy |
1,319
+359
| +37% | +$3.1K | ﹤0.01% | 4251 |
|
|
2023
Q1 | $8K | Sell |
960
-24,370
| -96% | -$220K | ﹤0.01% | 4622 |
|
|
2022
Q4 | $191K | Buy |
25,330
+18,958
| +298% | +$147K | 0.01% | 1330 |
|
|
2022
Q3 | $51K | Buy |
6,372
+5,221
| +454% | +$55.4K | ﹤0.01% | 3140 |
|
|
2022
Q2 | $14K | Sell |
1,151
-3,087
| -73% | -$36.4K | ﹤0.01% | 4135 |
|
|
2022
Q1 | $48K | Buy |
4,238
+1,955
| +86% | +$16.7K | ﹤0.01% | 2761 |
|
|
2021
Q4 | $15K | Sell |
2,283
-14,625
| -86% | -$100K | ﹤0.01% | 3981 |
|
|
2021
Q3 | $128K | Buy |
16,908
+15,605
| +1,198% | +$161K | ﹤0.01% | 2189 |
|
|
2021
Q2 | $16K | Sell |
1,303
-678
| -34% | -$7.46K | ﹤0.01% | 4077 |
|
|
2021
Q1 | $26K | Sell |
1,981
-3,841
| -66% | -$35.4K | ﹤0.01% | 3676 |
|
|
2020
Q4 | $20K | Sell |
5,822
-17,596
| -75% | -$66.1K | ﹤0.01% | 3869 |
|
|
2020
Q3 | $92K | Buy |
23,418
+16,604
| +244% | +$60.7K | ﹤0.01% | 3204 |
|
|
2020
Q2 | $36K | Buy |
+6,814
| New | +$31.4K | ﹤0.01% | 3303 |
|
|
2019
Q4 | – | Sell |
-396
| Closed | -$6K | – | 3745 |
|
|
2019
Q3 | $6K | Sell |
396
-664
| -63% | -$10.9K | ﹤0.01% | 3209 |
|
|
2019
Q2 | $15K | Buy |
1,060
+189
| +22% | +$3.75K | ﹤0.01% | 2337 |
|
|
2019
Q1 | $20K | Sell |
871
-4,858
| -85% | -$105K | ﹤0.01% | 2266 |
|
|
2018
Q4 | $68K | Buy |
+5,729
| New | +$81.7K | ﹤0.01% | 1137 |
|
|
2018
Q3 | – | Sell |
-6,555
| Closed | -$183K | – | 3888 |
|
|
2018
Q2 | $183K | Buy |
6,555
+5,794
| +761% | +$102K | 0.01% | 1107 |
|
|
2018
Q1 | $7K | Buy |
+761
| New | +$8.71K | ﹤0.01% | 2592 |
|
Other funds holding EOLS
NCM
B
FLSM
PA
SCM
Tower Research Capital (TRC)'s EOLS Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its Evolus (EOLS) stake by 62% in Q2 2026, selling an estimated $37.6K and leaving 3,852 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3303.
Tower Research Capital (TRC) first reported a position in EOLS in Q1 2018 and has held it in 31 quarters since. The position peaked at $237K in Q4 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- Tower Research Capital (TRC) held 3,852 shares of Evolus worth $26.7K as of Q2 2026.
- Tower Research Capital (TRC) sold 6,364 Evolus shares in Q2 2026, an estimated $37.6K.
- Evolus made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3303 holding.
- Tower Research Capital (TRC) first reported a position in Evolus in Q1 2018 and has held it in 31 quarters since.
- Tower Research Capital (TRC)'s Evolus position peaked at $237K in Q4 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.